- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
-
- 长期趋势：
已有65家主力机构披露2024-06-30报告期持股数据，持仓量总计8.54亿股，占流通A股38.61%
- 波段诊断：
-
技术面诊股
诊断结果：3.2技术面打败了66%的股票
技术面评分前10的股票
近期的平均成本为5.79元。
平均成本
近期的平均成本为5.79元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.79","date":1732175501,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2024.11.22","stock":"-4.55","trade":"-5.03","ind":"-3.52"},{"date":"2024.11.21","stock":"-1.66","trade":"-0.44","ind":"-0.07"},{"date":"2024.11.20","stock":"6.53","trade":"2.72","ind":"0.78"},{"date":"2024.11.19","stock":"1.80","trade":"2.39","ind":"1.90"},{"date":"2024.11.18","stock":"-2.28","trade":"-3.50","ind":"-1.91"},{"date":"2024.11.15","stock":"-3.39","trade":"-3.11","ind":"-2.62"},{"date":"2024.11.14","stock":"-5.90","trade":"-3.97","ind":"-2.83"},{"date":"2024.11.13","stock":"-4.42","trade":"-1.49","ind":"0.40"},{"date":"2024.11.12","stock":"10.07","trade":"1.61","ind":"-0.65"},{"date":"2024.11.11","stock":"0.17","trade":"2.97","ind":"2.03"},{"date":"2024.11.08","stock":"0.51","trade":"0.47","ind":"-0.66"},{"date":"2024.11.07","stock":"8.03","trade":"2.80","ind":"2.44"},{"date":"2024.11.06","stock":"0.37","trade":"0.63","ind":"-0.35"},{"date":"2024.11.05","stock":"1.30","trade":"3.90","ind":"3.22"},{"date":"2024.11.04","stock":"2.08","trade":"2.62","ind":"1.99"},{"date":"2024.11.01","stock":"-2.76","trade":"-2.50","ind":"-1.28"},{"date":"2024.10.31","stock":"1.12","trade":"0.69","ind":"0.57"},{"date":"2024.10.30","stock":"-1.83","trade":"-2.07","ind":"-0.12"},{"date":"2024.10.29","stock":"-2.15","trade":"-2.51","ind":"-1.33"},{"date":"2024.10.28","stock":"2.95","trade":"2.57","ind":"0.62"},{"date":"2024.10.25","stock":"2.45","trade":"4.70","ind":"1.71"}]
国际医学,深证成指,医疗服务指数
压力支撑
该股压力位为5.75元，支撑位为5.60元。
[{"text":"\u538b\u529b\u4f4d","value":"5.75","date":1732204800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.60","date":1732204800,"color":"0x0b52a1"}]
多空趋势
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.4资金面打败了44%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月22日 17:42
| 机构今日流向(万元) | -4065.40 | 机构5日流向(万元) | -6587.24 |
| 机构10日流向(万元) | -16446.50 | 机构20日流向(万元) | -18572.94 |
机构持仓
2024-06-30 与 2023-12-31 相比，主力机构持仓量增加14758.65万股，其中基金净减仓11家，主力净减仓123家，暂未发现中长期投资价值。
截止2024-06-30，共65家主力机构（基金59家，一般法人4家，券商1家，社保基金1家），持仓量总计85444.58万股，占流通A股38.61%
其中，基金持仓与2023-12-31相比：
增仓：10家 ，增持 535.57万股
减仓：21家 ，减持 3794.15万股
新出现在主力名单中：20家 ，持有4486.66万股
从主力名单中消失：143家 ，原持有17122.9万股
其中，基金持仓与2023-12-31相比：
增仓：10家 ，增持 535.57万股
减仓：21家 ，减持 3794.15万股
新出现在主力名单中：20家 ，持有4486.66万股
从主力名单中消失：143家 ，原持有17122.9万股
消息面诊股
诊断结果：5.5消息面打败了5%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 国际医学：11月21日获融资买入2269.22万元
2024-11-22 - 国际医学：11月20日获融资买入4512.82万元
2024-11-21 - 广发资管盛世精选混合A重仓股国际医学涨6.53%
2024-11-20 - 家庭医生板块异动拉升 国新健康、万达信息涨停
2024-11-20 - 国际医学：11月19日获融资买入1153.90万元
2024-11-20 - 医药2025：价值洼地，成长先行
2024-11-19 - 广发资管盛世精选混合A重仓股国际医学跌5.9%
2024-11-14 - 国际医学：11月13日获融资买入9627.56万元
2024-11-14 - 国际医学：11月12日获融资买入3225.08万元
2024-11-13 - 医保预付制度将完善，医疗机构、药企等有望受益！医药
2024-11-12
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-11-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-10-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-08-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-08-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-12 |
| 利好 | 业绩预告 | 预计减亏 | 2024-07-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-07-03 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-06-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-06-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-06-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-05-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-05-18 |
| 一般消息 | 股东大会 | 年度股东大会 | 2024-04-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-04-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-04-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-04-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-02-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-02-20 |
| 利好 | 业绩预告 | 预计减亏 | 2024-01-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2023-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2023-12-26 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2023-12-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.8行业面打败了69%的股票
医疗服务行业最新资金流向
近10日来该行业走势总体向下，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，接近大盘。
[{"date":"2024.11.22","price":"-3.52","value":"-5.03"},{"date":"2024.11.21","price":"-0.07","value":"-0.44"},{"date":"2024.11.20","price":"0.78","value":"2.72"},{"date":"2024.11.19","price":"1.90","value":"2.39"},{"date":"2024.11.18","price":"-1.91","value":"-3.50"},{"date":"2024.11.15","price":"-2.62","value":"-3.11"},{"date":"2024.11.14","price":"-2.83","value":"-3.97"},{"date":"2024.11.13","price":"0.40","value":"-1.49"},{"date":"2024.11.12","price":"-0.65","value":"1.61"},{"date":"2024.11.11","price":"2.03","value":"2.97"},{"date":"2024.11.08","price":"-0.66","value":"0.47"},{"date":"2024.11.07","price":"2.44","value":"2.80"},{"date":"2024.11.06","price":"-0.35","value":"0.63"},{"date":"2024.11.05","price":"3.22","value":"3.90"},{"date":"2024.11.04","price":"1.99","value":"2.62"},{"date":"2024.11.01","price":"-1.28","value":"-2.50"},{"date":"2024.10.31","price":"0.57","value":"0.69"},{"date":"2024.10.30","price":"-0.12","value":"-2.07"},{"date":"2024.10.29","price":"-1.33","value":"-2.51"},{"date":"2024.10.28","price":"0.62","value":"2.57"},{"date":"2024.10.25","price":"1.71","value":"4.70"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 皓宸医疗 | 20.08% | -9.75% | 4.3分 |
| 2 | 美年健康 | 18.98% | 2.73% | 4.9分 |
| 3 | 普瑞眼科 | 14.21% | -4.78% | 4.4分 |
| 4 | ST中珠 | 13.71% | -3.42% | 4.7分 |
| 5 | 创新医疗 | 9.77% | -10.21% | 3.6分 |
| 6 | 毕得医药 | 9.23% | 0.98% | 4.4分 |
| 8 | 奥浦迈 | 7.65% | 2.59% | 5.1分 |
| 10 | 凯莱英 | 3.70% | 1.13% | 4.2分 |
| 12 | 光正眼科 | 2.29% | -5.63% | 4.4分 |
| 14 | 海特生物 | 0.57% | -3.70% | 3.8分 |
| 16 | 新里程 | -0.76% | -4.74% | 4.3分 |
| 18 | 南华生物 | -1.76% | 3.81% | 4.4分 |
| 20 | 诚达药业 | -3.28% | -7.16% | 3.7分 |
| 22 | 泓博医药 | -3.86% | -9.99% | 4.2分 |
| 24 | 益诺思 | -4.09% | -5.49% | 3.8分 |
| 26 | 诺泰生物 | -4.33% | -3.91% | 4.9分 |
| 28 | 爱尔眼科 | -4.67% | -5.37% | 4.4分 |
| 30 | 华厦眼科 | -5.02% | -6.68% | 3.9分 |
| 32 | 盈康生命 | -5.64% | -4.70% | 4.5分 |
| 34 | 药明康德 | -6.36% | -6.13% | 4.4分 |
| 36 | 诺思格 | -6.74% | -1.05% | 4.1分 |
| 38 | 成都先导 | -7.15% | -9.99% | 4.2分 |
| 40 | 博济医药 | -7.65% | -3.98% | 4.3分 |
| 42 | 普蕊斯 | -9.18% | -2.03% | 4.3分 |
| 44 | 百花医药 | -9.66% | -4.02% | 4.5分 |
| 46 | 药康生物 | -9.95% | -3.58% | 4.7分 |
| 48 | 阳光诺和 | -10.84% | -4.46% | 5.1分 |
| 50 | 药石科技 | -11.59% | -5.26% | 3.7分 |
| 52 | 泰格医药 | -13.69% | -1.70% | 5.0分 |
| 54 | - | - | 153.01% | 分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 国信证券 | 2012-09-12 | 增持 | 增持 |
| 国海证券 | 2012-09-11 | 中性 | - |
| 东兴证券 | 2012-09-11 | 增持 | 增持 |
| 平安证券 | 2012-09-10 | 增持 | 增持 |
| 华融证券 | 2012-09-10 | 中性 | 中性 |
更多>>行业资讯
- 2012-09-13海岛建设股东股权质押
- 2012-09-13工大首创简式权益变动
- 2012-09-13华联综超选举公司第五届董事会董事长
- 2012-09-13积极追随政策把握市场热点方向
- 2012-09-13商贸零售行业：行业拐点仍需等待 选择确定性增长公司
- 2012-09-13卡奴迪路调研简报：渠道逆势持续扩张 明年增长新亮点
- 2012-09-13传言家乐福将退出中国市场 专家称可能性甚微
- 2012-09-13外资零售巨头在华遭遇困顿 专家分析八大原因
- 2012-09-13外资零售企业也须与时俱进
- 2012-09-13商务部谈电商价格战：正起草电子商务管理条例
基本面诊股
[ 截止日期：2024-09-30 ]公司经营
盈利能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 51/96 ， 51/96。
[{"date":"2024-09-30","value":"-5.61","vol":"3.45"},{"date":"2024-06-30","value":"-4.57","vol":"2.65"},{"date":"2024-03-31","value":"-2.72","vol":"1.13"},{"date":"2023-12-31","value":"-9.03","vol":"4.72"},{"date":"2023-09-30","value":"-5.36","vol":"6.22"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-5.61 | -4.57 | -2.72 | -9.03 | -5.36 |
| 行业(%) | 3.45 | 2.65 | 1.13 | 4.72 | 6.22 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"9.19","vol":"36.79"},{"date":"2024-06-30","value":"9.49","vol":"36.95"},{"date":"2024-03-31","value":"7.84","vol":"36.12"},{"date":"2023-12-31","value":"9.55","vol":"39.51"},{"date":"2023-09-30","value":"8.83","vol":"40.64"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
9.19 | 9.49 | 7.84 | 9.55 | 8.83 |
| 行业(%) | 36.79 | 36.95 | 36.12 | 39.51 | 40.64 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/96 ， 14/96。
[{"date":"2024-09-30","value":"7.85","vol":"2.30"},{"date":"2024-06-30","value":"9.53","vol":"2.66"},{"date":"2024-03-31","value":"10.75","vol":"4.69"},{"date":"2023-12-31","value":"70.34","vol":"10.34"},{"date":"2023-09-30","value":"74.70","vol":"9.88"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
7.85 | 9.53 | 10.75 | 70.34 | 74.70 |
| 行业(%) | 2.30 | 2.66 | 4.69 | 10.34 | 9.88 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"4.59","vol":"-152.72"},{"date":"2024-06-30","value":"21.89","vol":"-97.56"},{"date":"2024-03-31","value":"-40.37","vol":"-46.85"},{"date":"2023-12-31","value":"68.69","vol":"0.01"},{"date":"2023-09-30","value":"73.12","vol":"-386.50"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
4.59 | 21.89 | -40.37 | 68.69 | 73.12 |
| 行业(%) | -152.72 | -97.56 | -46.85 | 0.01 | -386.50 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 26/96 ， 4/96。
[{"date":"2024-09-30","value":"0.33","vol":"0.31"},{"date":"2024-06-30","value":"0.22","vol":"0.20"},{"date":"2024-03-31","value":"0.11","vol":"0.10"},{"date":"2023-12-31","value":"0.38","vol":"0.43"},{"date":"2023-09-30","value":"0.27","vol":"0.32"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.33 | 0.22 | 0.11 | 0.38 | 0.27 |
| 行业(次) | 0.31 | 0.20 | 0.10 | 0.43 | 0.32 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"37.03","vol":"13.99"},{"date":"2024-06-30","value":"28.67","vol":"8.71"},{"date":"2024-03-31","value":"14.01","vol":"4.51"},{"date":"2023-12-31","value":"56.61","vol":"19.08"},{"date":"2023-09-30","value":"37.92","vol":"11.28"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
37.03 | 28.67 | 14.01 | 56.61 | 37.92 |
| 行业(次) | 13.99 | 8.71 | 4.51 | 19.08 | 11.28 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2024-09-30","value":"8.28","vol":"12.31"},{"date":"2024-06-30","value":"24.55","vol":"10.34"},{"date":"2024-03-31","value":"18.69","vol":"0.77"},{"date":"2023-12-31","value":"31.25","vol":"24.44"},{"date":"2023-09-30","value":"24.59","vol":"16.37"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 8.28 | 24.55 | 18.69 | 31.25 | 24.59 |
| 行业 | 12.31 | 10.34 | 0.77 | 24.44 | 16.37 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"0.99","vol":"1.47"},{"date":"2024-03-31","value":"","vol":"0.00"},{"date":"2023-12-31","value":"0.97","vol":"2.51"},{"date":"2023-09-30","value":"","vol":"0.00"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.99 | - | 0.97 | - |
| 行业 | 0.00 | 1.47 | 0.00 | 2.51 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 32/96 ， 18/96。
[{"date":"2024-09-30","value":"0.37","vol":"4.06"},{"date":"2024-06-30","value":"0.40","vol":"4.09"},{"date":"2024-03-31","value":"0.43","vol":"4.35"},{"date":"2023-12-31","value":"0.46","vol":"4.20"},{"date":"2023-09-30","value":"0.51","vol":"4.21"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.37 | 0.40 | 0.43 | 0.46 | 0.51 |
| 行业 | 4.06 | 4.09 | 4.35 | 4.20 | 4.21 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"0.33","vol":"3.34"},{"date":"2024-06-30","value":"0.36","vol":"3.35"},{"date":"2024-03-31","value":"0.39","vol":"3.57"},{"date":"2023-12-31","value":"0.43","vol":"3.49"},{"date":"2023-09-30","value":"0.47","vol":"3.65"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.33 | 0.36 | 0.39 | 0.43 | 0.47 |
| 行业 | 3.34 | 3.35 | 3.57 | 3.49 | 3.65 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 17/96 ， 4/96。
[{"date":"2024-09-30","value":"67.04","vol":"31.14"},{"date":"2024-06-30","value":"67.04","vol":"31.74"},{"date":"2024-03-31","value":"66.16","vol":"31.10"},{"date":"2023-12-31","value":"66.29","vol":"32.13"},{"date":"2023-09-30","value":"64.03","vol":"30.93"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
67.04 | 67.04 | 66.16 | 66.29 | 64.03 |
| 行业(%) | 31.14 | 31.74 | 31.10 | 32.13 | 30.93 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2024-09-30","value":"1.94","vol":"0.84"},{"date":"2024-06-30","value":"1.95","vol":"0.86"},{"date":"2024-03-31","value":"1.89","vol":"0.91"},{"date":"2023-12-31","value":"1.92","vol":"1.05"},{"date":"2023-09-30","value":"1.76","vol":"1.70"}]
| 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.94 | 1.95 | 1.89 | 1.92 | 1.76 |
| 行业(%) | 0.84 | 0.86 | 0.91 | 1.05 | 1.70 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华创证券 | 2024-11-09 | 增持 | |
| 中信证券 | 2024-10-29 | 买入 | 买入 |
| 东海证券 | 2024-10-28 | 买入 | 买入 |
| 华安证券 | 2024-10-27 | 买入 | |
| 中邮证券 | 2024-10-25 | 买入 | 买入 |
| 国金证券 | 2024-10-25 | 买入 |
机构预测
机构预测该股2024年每股收益与前一年相同，长期投资价值一般。
[{"date":"2020","yellowRectValue":"0.45","blueLineValue":"","type":""},{"date":"2021","yellowRectValue":"-8.22","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-11.77","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.68","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-1.43","blueLineValue":"-0.06","type":"YC"}]